September 18, 2013 | Israeli biotech startup CureTech, which develops innovative ways to treat cancer, has raised $3.8 million. The finances were raised in a rights issue to majority shareholder Clal.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments